Cognitive and Pathological Influences of Tau Pathology in Lewy Body Disorders

Keywords

Computer science

References

• Colocalization of Tau and Alpha‐Synuclein Epitopes in Lewy BodiesTakashi Ishizawa, P. M. Mattila, Peter Davies — 2003
• Longitudinal study of normal cognition in Parkinson diseaseKara Pigott, Jacqueline Rick, Sharon X. Xie — 2015
• The spectrum of cognitive impairment in Lewy body diseasesJennifer G. Goldman, Caroline H. Williams‐Gray, Roger A. Barker — 2014
• Phases of Aβ-deposition in the human brain and its relevance for the development of ADDietmar Rudolf Thal, Udo Rüb, M Orantes — 2002
• Convergence of Lewy bodies and neurofibrillary tangles in amygdala neurons of Alzheimer’s disease and Lewy body disordersMaria Luiza Gava Schmidt, John A. Martin, Virginia M.‐Y. Lee — 1996
• Association analysis of MAPT H1 haplotype and subhaplotypes in Parkinson's diseaseCyrus P. Zabetian, Carolyn M. Hutter, Stewart A. Factor — 2007
• Neuropathology underlying clinical variability in patients with synucleinopathiesGlenda M. Halliday, Janice L. Holton, Tamás Révész — 2011
• Cognitive differences in dementia patients with autopsy-verified AD, Lewy body pathology, or bothMatthew Kraybill, Eric B. Larson, Debby W. Tsuang — 2005
• Neuropsychological assessment in collaborative Parkinson’s disease researchG. Stennis Watson, Brenna Cholerton, Owen A. Ross — 2012
• Alpha-synuclein cortical Lewy bodies correlate with dementia in Parkinson’s diseaseHoward I. Hurtig, John Q. Trojanowski, James E. Galvin — 2000
• Impact of coexistent Alzheimer pathology on the natural history of Parkinson's diseaseK. A. Jellinger, Klaus Seppi, Gregor K. Wenning — 2002
• Lewy- and Alzheimer-type pathologies in Parkinson’s disease dementia: which is more important?Yaroslau Compta, Laura Parkkinen, Sean S. O’Sullivan — 2011
• Novel antibodies to synuclein show abundant striatal pathology in Lewy body diseasesJohn E. Duda, Benoit I. Giasson, Meghann E. Mabon — 2002
• Parkinson's disease dementia: convergence of α-synuclein, tau and amyloid-β pathologiesDavid J. Irwin, Virginia M.‐Y. Lee, John Q. Trojanowski — 2013
• Neuropathological stageing of Alzheimer-related changesHeiko Braak, Eva Braak — 2004
• Neuropathologically mixed Alzheimer’s and Lewy body disease: burden of pathological protein aggregates differs between clinical phenotypesLauren Walker, Kirsty E. McAleese, Alan Thomas — 2015
• The progression of pathology in longitudinally followed patients with Parkinson’s diseaseGlenda M. Halliday, M. A. Hely, Wayne G.J. Reid — 2008
• Variable expression of Parkinson's diseaseJoseph Jankovic, Michael McDermott, Jonathan Carter — 1990
• Staging of brain pathology related to sporadic Parkinson's disease.Heiko Braak, Kelly Del Tredici, Udo Rüb — 2003
• Initiation and Synergistic Fibrillization of Tau and Alpha-SynucleinBenoit I. Giasson, Mark S. Forman, Makoto Higuchi — 2003

Cited by

• The Contribution of Tau, Amyloid-Beta and Alpha-Synuclein Pathology to Dementia in Lewy Body DisordersDavid J. Irwin, Howard I. Hurtig — 2018
• Clinical and neuropathological differences between Parkinson's disease, Parkinson's disease dementia and dementia with Lewy bodies – current issues and future directionsLauren Walker, Leonidas Stefanis, Johannes Attems — 2019
• Most Cases with Lewy Pathology in a Population-Based Cohort Adhere to the Braak Progression Pattern but ‘Failure to Fit’ is Highly Dependent on Staging System AppliedDavid G. Coughlin, Helen Petrovitch, Lon R. White — 2019
• Tau is required for progressive synaptic and memory deficits in a transgenic mouse model of α-synucleinopathyBalvindar Singh, Ana Covelo, Héctor Martell-Martínez — 2019
• Empiric Methods to Account for Pre-analytical Variability in Digital Histopathology in Frontotemporal Lobar DegenerationLucia Giannini, Sharon X. Xie, Claire Peterson — 2019
• Neuropathology and pathogenesis of extrapyramidal movement disorders: a critical update—I. Hypokinetic-rigid movement disordersK. A. Jellinger — 2019
• Sleep Disturbance as Potential Risk and Progression Factor for Parkinson’s DiseaseNicolaas I. Bohnen, Michele T.M. Hu — 2019
• Alzheimer’s disease clinical variants show distinct regional patterns of neurofibrillary tangle accumulationCathrine Petersen, Amber Nolan, Elisa de Paula França Resende — 2019
• Clinical Correlates of Cerebral Amyloid Deposition in Parkinson’s Disease Dementia: Evidence from a PET StudyGiovanni Palermo, Luca Tommasini, Gayanè Aghakhanyan — 2019
• In vivo Prevalence of Alzheimer Biomarkers in Dementia with Lewy BodiesGeorge P. Paraskevas, Anastasia Bougea, Vasilios C. Constantinides — 2019
• The bivariate distribution of amyloid-β and tau: relationship with established neurocognitive clinical syndromesClifford R. Jack, Heather J. Wiste, Hugo Botha — 2019
• Pathological Influences on Clinical Heterogeneity in Lewy Body DiseasesDavid G. Coughlin, Howard I. Hurtig, David J. Irwin — 2019
• Alzheimer’s disease tau is a prominent pathology in LRRK2 Parkinson’s diseaseMichael X. Henderson, Medha Sengupta, John Q. Trojanowski — 2019
• The future of stem cell therapies for Parkinson diseaseMalin Parmar, Shane Grealish, Claire Henchcliffe — 2020
• Cognitive impairment in Parkinson's disease is multifactorial: A neuropsychological studyCallum Smith, Breda Cullen, Matthew P. Sheridan — 2020
• When does cerebral β‐amyloid deposition begin in Lewy body dementia?Hiroshige Fujishiro, Kenji Kosaka — 2020
• Evolution of Alzheimer’s Disease Cerebrospinal Fluid Biomarkers in Early Parkinson’s DiseaseDavid J. Irwin, Janel Fedler, Christopher S. Coffey — 2020
• Subtypes of dementia with Lewy bodies are associated with α-synuclein and tau distributionTanis J. Ferman, Naoya Aoki, Bradley F. Boeve — 2020
• The combined effect of amyloid-β and tau biomarkers on brain atrophy in dementia with Lewy bodiesCarla Abdelnour, Daniel Ferreira, Ketil Oppedal — 2020
• Normal Pressure Hydrocephalus Associated with Alzheimer's DiseaseKatharina Müller‐Schmitz, Natalia Krasavina‐Loka, Tuğba Yardımcı Gürel — 2020

Related papers

No related papers recorded.